Form 8-K - Current report:
SEC Accession No. 0001140361-24-048475
Filing Date
2024-12-05
Accepted
2024-12-05 16:14:08
Documents
13
Period of Report
2024-12-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ef20039631_8k.htm   iXBRL 8-K 24394
  Complete submission text file 0001140361-24-048475.txt   158154

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rckt-20241202.xsd EX-101.SCH 3995
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20241202_lab.xml EX-101.LAB 21967
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20241202_pre.xml EX-101.PRE 16053
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20039631_8k_htm.xml XML 4057
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 241529248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)